Abivax S.A. (ABVX) Form 10-Q Quarterly Reports
Abivax S.A. (ABVX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ABVX
CIK: 1956827
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: I0
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PRICEWATERHOUSECOOPERS AUDIT
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerRENAUD ROGUINSKY
Audit LocationNEUILLY-SUR-SEINE, France
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| F-6EF | 2026-09-21 | — | F-6EF Filing | 0001193805-26-001261 | View SEC Doc Filr Page |
| 6-K | 2026-09-21 | 2026-06-30 | 6-K | 0001956827-26-000027 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-352351 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0002005369-26-000043 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-06 | — | SCHEDULE 13D/A Filing | 0001104659-26-080877 | View SEC Doc Filr Page |
| 6-K | 2026-07-02 | 2026-07-02 | 6-K | 0001193125-26-294514 | View SEC Doc Filr Page |
| 424B5 | 2026-07-02 | — | 424B5 | 0001193125-26-294491 | View SEC Doc Filr Page |
| FWP | 2026-07-01 | — | FWP | 0001193125-26-291689 | View SEC Doc Filr Page |
| FWP | 2026-06-30 | — | FWP | 0001193125-26-290857 | View SEC Doc Filr Page |
| 424B5 | 2026-06-30 | — | 424B5 | 0001193125-26-290817 | View SEC Doc Filr Page |
| POSASR | 2026-06-30 | — | POSASR | 0001193125-26-290578 | View SEC Doc Filr Page |
| 6-K | 2026-06-29 | 2026-06-29 | 6-K | 0001193125-26-288752 | View SEC Doc Filr Page |
| 6-K | 2026-06-02 | 2026-06-01 | 6-K | 0001193125-26-252360 | View SEC Doc Filr Page |
| 6-K | 2026-05-22 | 2026-03-31 | 6-K | 0001956827-26-000022 | View SEC Doc Filr Page |
| 6-K | 2026-05-20 | 2026-05-20 | 6-K | 0001956827-26-000017 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-05-11 | — | SCHEDULE 13D/A Filing | 0001104659-26-058492 | View SEC Doc Filr Page |
| 6-K | 2026-05-07 | 2026-05-07 | 6-K | 0001193125-26-211853 | View SEC Doc Filr Page |
| 424B7 | 2026-05-07 | — | 424B7 | 0001193125-26-210978 | View SEC Doc Filr Page |
| 6-K | 2026-04-20 | 2026-04-20 | 6-K | 0001956827-26-000014 | View SEC Doc Filr Page |
| S-8 | 2026-03-23 | — | S-8 | 0001193125-26-120026 | View SEC Doc Filr Page |
| 20-F | 2026-03-23 | 2025-12-31 | 20-F | 0001956827-26-000012 | View SEC Doc Filr Page |
| 6-K | 2026-03-23 | 2025-12-31 | 6-K | 0001956827-26-000010 | View SEC Doc Filr Page |
| 6-K | 2026-02-23 | 2026-02-21 | 6-K | 0001956827-26-000003 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-13 | — | SCHEDULE 13G/A Filing | 0002005369-26-000006 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-01-14 | — | SCHEDULE 13D/A Filing | 0001104659-26-003743 | View SEC Doc Filr Page |